The William Harvey Research Institute is one of the UK's leading research-focused higher education institutes. We offer world-class research training for our Postgraduate Research students encompassing discovery and translational research in the areas of cardiovascular pharmacology, immunology, endocrinology and genomics.
In the area of cardiovascular sciences, a key element of our NIHR Barts Biomedical Research Centre is the creation of a Translational Cardiovascular Medicine Academy. Since 2013, this has been enhanced by our BHF 4-year MRes/PhD Programme. This provides students of the highest calibre with an opportunity to receive training in cardiovascular science from the molecular and cellular level, to in vivo models to healthy volunteer and patient-based studies.
Since October 2013 WHRI has been one of nine UK centres hosting a British Heart Foundation 4 year MRes/PhD programme. For outstanding applicants this programme consists of an MRes course for the first year of study, providing students with the foundation knowledge and abilities they need to proceed to their cardiovascular PhD training.
Visit the BHF 4 year MRes/PhD Programme webpage for more information.
EVOluTION is a Marie Sklodowska-Curie Actions Innovative Training Network (ITN) doctoral programme designed to provide multidisciplinary training for 11 PhD students on preclinical and clinical research, commercial and business opportunities and intellectual property. The science of EVOluTION is based on boosting the natural protective mechanisms operating in our body, to generate innovative therapeutic strategies in the management of chronic vascular and metabolic diseases. The interdisciplinary and cross-cutting research performed by the students will lead to novel therapeutic tools and a scientific perspective to address challenging medical, societal and industrial issues. Moreover, this ITN will deliver high level scientific and complementary training to create a new generation of scientists that are entrepreneurially minded and skilled in research and business. As such EVOluTION is perfectly aligned with the research vision of the WHRI.
Visit the programme website for more information.
For further programme information please email Professor John Marshall.
For more information please email Professor Paul Chapple.
We frequently advertise stand-alone PhD studentships funded by charitable bodies, industry and Queen Mary University of London.
For further information please visit Research degrees in Medicine and Dentistry.
During their studies, the progression of each research student is closely monitored. For PhD and MD(Res) students, there are progression points at 9, 18 and 30 months when students produce interim reports of their progress and future plans for consideration by two independent assessors in conjunction with reports from the supervisors. Students also present at ‘Research In Progress’ meetings, at which PhD students and junior post-doctoral researchers share their on-going experimental work with researchers from across the WHRI.
Within Barts and the London School of Medicine and Dentistry, all students participate fully in a doctoral development training scheme, based on the Vitae Researcher Development Framework. This approach means that students are well prepared to become successful independent researchers and fully equipped with the necessary skills to enter the workplace. During their training period, students work with their supervisors and independent assessors to identify their individual training needs. In addition to opportunities within WHRI, students can undertake training programs from a range of activities offered by the wider School of Medicine and Dentistry and by QMUL’s Learning Institute.
Our aim is to provide all our students with the experience of cutting-edge research conducted at the highest level, coupled with the attainment of the transferable skills essential for success in research and research-related careers. Former students and fellows include Professors at Yale, Singapore, Frankfurt, Washington, and institutions throughout the UK, as well as CEOs and R&D Directors of major companies.